Related Experiment Videos
CDCR with buccal mucosal graft: comparative and histopathological study
1Department of Ophthalmology, Ankara Numune Hospital, Turkey.
Summary
Conjunctivodacryocystorhinostomy (CDCR) with buccal mucosal graft shows promise for epiphora treatment, reducing complications. However, early tube removal may not be ideal, requiring further study.
Area of Science:
- Ophthalmology
- Oculoplastics
- Surgical Innovation
Background:
- Conjunctivodacryocystorhinostomy (CDCR) effectively treats epiphora but often involves frequent post-operative complications and tube replacement.
- Alternative techniques are explored to mitigate the adverse effects associated with indwelling tubes in CDCR.
Purpose of the Study:
- To evaluate the efficacy and safety of a modified CDCR technique using a Jones tube surrounded by a buccal mucosal graft.
- To compare the outcomes of this novel technique with traditional CDCR procedures.
Main Methods:
- Fourteen patients underwent CDCR with a Jones tube and buccal mucosal graft between September 1995 and March 1997.
- Results were retrospectively compared to a previous series of 22 patients who had undergone traditional CDCR.
Main Results:
- All cases achieved functional success, resolving epiphora with a mean follow-up of 13.7 months.
- While complications were reduced compared to traditional CDCR, graft degeneration was observed in biopsies, and tube removal at six months led to passage blockage in most cases.
- Two patients required reinsertion due to tube displacement, and one experienced graft extrusion.
Conclusions:
- CDCR with buccal mucosal graft appears to be a safe and effective method for epiphora treatment, with a lower incidence of complications during the tube indwelling period.
- Early tube removal at six months post-operatively is not recommended.
- Further research with larger patient cohorts and extended follow-up is necessary to validate the long-term benefits of this technique.